Center of
              Research Translation in Scleroderma
<--Back to UT-CORT Homepage


1. CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in PatientsAQ1 With Early Systemic Sclerosis Data from Two Independent Cohorts.

2. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheum. (submitted)

3. Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis. Arthritis Rheum. 2013 Jul 29. [Epub ahead of print]

4. Secondary use of existing public microarray data to predict outcome for hepatocellular carcinoma (submitted)

5. Systemic sclerosis and Lupus: Points in an interferon-mediated continuum. Arthritis Rheum, 2010, 62:589-598

6. Major histocompatibility complex (MHC) class II alleles and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasina, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010 69: 822-827

7. Signatures of differentially regulated interferon gene expression and vasculotropism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford), 2006, 45: 694-702

8. Clinically discordant scleroderma monozygotic twins show concordance for fibroblast gene expression profiles. Arthritis Rheum, 2005, 52: 3305-3314

9. Classification analysis of the transcriptosome of non-lesional cultured dermal fibroblasts from scleroderma patients with early disease. Arthritis Rheum 2005, 52:865-876